Bevacizumab (intra-ocular)

OFFICE ADMINISTRATION: Sterile environment / Aseptic technique

Indications for Prior Authorization:

  • Neovascular (WET) age related Macular Degeneration (AMD)
  • Macular retinal edema
  • Diabetic macular edema
  • Cystoid macular degeneration
  • Rubeosis iridis
  • Choroidal neovascularization, one or more of the following:
  • Angioid streaks
  • Choroiditis
  • Degenerative myopia
  • Retinal dystrophies
  • Neovascular glaucoma
  • Retinal vein occlusion (branch or central)

The following indications do not meet the criteria for use established by the Western Health Advantage Pharmacy and Therapeutics Committee:

  • Any other diagnosis not listed in the approved indications

Dosing:

  • Up to 2.5mg every 4 weeks by intravitreal injection

Monitoring:

  • Elevation in intraocular pressure ocular inflammation (endophthalmitis) immediately after injection check for perfusion of the optic nerve head measure intraocular pressure (tonometry) within 30 minutes following injection slit lamp biomicroscopy between 2 and 7 days following injection

 

Last review date: December 2, 2013

Rite Aid Pharmacy Patients: All Rite Aid pharmacies nationwide are closing! Please be on the lookout for information from Rite Aid pharmacies about their bankruptcy and store closures. Call your Rite Aid pharmacy for questions about your prescriptions and new pharmacy options. WHA is here to help as well. Contact Us via Phone